Search Results



Article Topics

Your search for Leo I. Gordon, MD, FACP matches 1 pages

Showing 1 - 1


leukemia

Idelalisib in Resistant CLL: Benefit Shown, Questions Remain

As reported in The Lancet Oncology by Dr. Andrew Zelenetz and colleagues and reviewed in this issue of The ASCO Post, an international phase III trial in 416 patients with refractory or recurrent chronic lymphocytic leukemia (CLL) addressed the benefit of adding the first-in-class phosphoinositide...

Advertisement



Advertisement


Advertisement